These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6741861)

  • 1. Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot study.
    Earhart RH; Moertel C; Hahn RG; Woodhouse CL; Ramirez G; Engstrom PF
    Am J Clin Oncol; 1984 Aug; 7(4):309-12. PubMed ID: 6741861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study.
    Earhart RH; Muggia FM; Golomb FM
    Invest New Drugs; 1985; 3(3):297-301. PubMed ID: 4066223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCNU: phase II evaluation in advanced colorectal carcinoma.
    Pazdur R; Samson MK; Baker LH
    Invest New Drugs; 1988 Jun; 6(2):93-5. PubMed ID: 3170134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancer.
    Bedikian AY; Stroehlein JR; Karlin DA; Bennetts RW; Stewart DJ; Bodey GP
    Am J Clin Oncol; 1983 Feb; 6(1):49-52. PubMed ID: 6837507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phase II study of the water-soluble nitrosourea compound ACNU in advanced colorectal carcinomas].
    Fiebig HH; Wellens W; Peukert M; Henss H; Arnold H; Westerhausen M; Löhr GW
    Onkologie; 1984 Dec; 7(6):370-7. PubMed ID: 6396565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of chlorozotocin in advanced large bowel carcinoma. A cooperative study between two institutions.
    Schutt AJ; Hoth D; Moertel CG; Schein PS; Rubin J; O'Connell MJ
    Am J Clin Oncol; 1984 Oct; 7(5):507-11. PubMed ID: 6239538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of PCNU in breast carcinoma.
    Rubins JM; Taylor SG
    Invest New Drugs; 1989 Jul; 7(2-3):239-41. PubMed ID: 2793380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of PCNU in colorectal carcinoma.
    Mitchell EP; Killen JY; Smith FP; Willis LL; Schein PS; Woolley PV
    Cancer Treat Rep; 1981; 65(11-12):1129-30. PubMed ID: 7296558
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II study of doxifluridine in advanced colorectal adenocarcinoma.
    Abele R; Alberto P; Kaplan S; Siegenthaler P; Hofmann V; Ryssel HJ; Hartmann D; Holdener EE; Cavalli F
    J Clin Oncol; 1983 Dec; 1(12):750-4. PubMed ID: 6230419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trail of PCNU in refractory advanced breast cancer.
    Kavanagh JJ; Yap HY; Blumenschein GR; Stewart D; Bodey GP
    Am J Clin Oncol; 1982 Jun; 5(3):249-51. PubMed ID: 7081144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors.
    Feun LG; Stewart DJ; Leavens ME; Burgess MA; Savaraj N; Benjamin RS; Bodey GP
    J Neurooncol; 1983; 1(1):45-8. PubMed ID: 6678305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of intracarotid PCNU.
    Stewart DJ; Grahovac Z; Russel NA; Hugenholtz H; Gupta S; Benoit BC; Richard MT; Maroun JA; Hopkins HS; Locke L
    J Neurooncol; 1987; 5(3):245-50. PubMed ID: 3681387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCNU and recurrent childhood brain tumors.
    Allen JC; Hancock C; Walker R; Tan C
    J Neurooncol; 1987; 5(3):241-4. PubMed ID: 3681386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CBDCA: phase II evaluation in advanced colorectal carcinoma.
    Pazdur R; Samson MK; Baker LH
    Am J Clin Oncol; 1987 Apr; 10(2):136-8. PubMed ID: 3551576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCNU in advanced adenocarcinoma of the ovary: a phase II study.
    Decker DA; Samson MJ; Baker LH
    Cancer Treat Rep; 1983 May; 67(5):511-2. PubMed ID: 6850668
    [No Abstract]   [Full Text] [Related]  

  • 17. The lethal activity and repair inhibition capacity of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466, PCNU), a nitrosourea with low carbamoylating activity.
    Drewinko B; Yang LY
    Invest New Drugs; 1983; 1(3):197-202. PubMed ID: 6678867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273).
    Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P
    Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU)(NSC-95466) in patients with advanced carcinoma of the lung.
    Ratanatharathorn V; Samson MK; Haas CD; Cummings GD; O'Connor EJ; Baker LH
    Am J Clin Oncol; 1983 Feb; 6(1):99-102. PubMed ID: 6837509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
    Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.